然而，传统手术依赖医生经验，存在操作不稳定、精准度不足等问题，导致患者术后康复周期长、疗效不确定性较高。这些问 题已成为骨科诊疗领域的重要挑战。 智能技术攻克传统手术难题 在骨科疾病中，关节老化磨损采取人工关节置换手术解决，这是提升患者运动能力的常用方式之一。 7月24日，在关节置换手术机器人的辅助下，潍坊市中医院关节骨二科分别完成全膝关节置换手术和全髋关节置换手术，术中监 测假体放置误差小于1毫米，是山东省中医药系统率先开展机器人辅助关节置换手术的医院。 术中导航 系统实时监测手术工具的位置和力度，对照术前模型进行校正。如有偏差，立即报警并提供纠正引导，同时动态调整以适应患 者个体差异。 针对这些痛点，潍坊市中医院引入手术机器人，开启了"数字骨科+智能手术"新模式。 关节骨二科主任张振鹏介绍，该机器人能执行膝关节置换、全髋关节置换、单髁关节置换、脊柱手术和创伤手术等任务，以专 业化、精细化、特色化的方式，全面提升手术精准度与安全性。 或许您会好奇：机器人也能手术？ 这并非科幻情节，而是医疗领域的突破性技术——它作为医生的"超级助手"，协同完成高精度操作。 关节置换手术机器人的工作原理 关节置换手术机器人是一 ...

Core Insights - The SRT-H robot has successfully performed a gallbladder removal surgery autonomously, marking a significant advancement in surgical robotics [1][2] - This robot demonstrates the ability to adapt in real-time to individual anatomical structures and make instant decisions, showcasing a leap from merely executing tasks to understanding surgical procedures [2][3] - The robot achieved a 100% success rate in surgery, even under non-standard anatomical conditions and unexpected visual interferences, indicating its robustness and reliability [2][3] Group 1 - The SRT-H robot is capable of recognizing and responding to voice commands, allowing for interactive learning and behavior optimization [2] - The surgery involved 17 complex steps, requiring precise identification and manipulation of anatomical structures, which the robot managed effectively [2] - The development of the SRT-H robot addresses fundamental challenges in deploying autonomous surgical systems in real-world scenarios [3] Group 2 - The SRT-H robot represents a paradigm shift in surgical robotics, moving from task execution to a deeper understanding of surgical contexts [3] - This advancement is expected to alleviate the shortage of surgical resources and enhance medical service capabilities in remote or extreme environments [3]

Core Viewpoint - The medical robotics industry has entered a complex phase by 2025, with evolving product forms, clearer clinical pathways, and a more rational capital environment, emphasizing the need for a comprehensive ecosystem [1] Group 1: Event Overview - The Third Global Surgical Robotics Conference will take place from September 4-6, 2025, in Beijing, focusing on the theme "MedRobot Next: The Future of Technology" [2] - The conference serves as a platform for discussing technological advancements, supply chain transformations, hospital system upgrades, and international trends [1][2] Group 2: Key Themes - The conference will cover topics such as the systematic upgrade of intelligent surgical systems, the construction of a full-chain ecosystem, and global pathways for development [1] - It aims to redefine how hospitals will be reconstructed through robotics, moving beyond just equipment discussions [1][12] Group 3: Industry Insights - The event will feature the launch of the "Global Surgical Robotics Industry Report 2025" and an annual industry awards ceremony [3] - Discussions will include the integration of clinical needs into engineering goals, the evolution of surgical robots across various specialties, and the challenges of integrating robotic systems into hospital frameworks [7][13] Group 4: Commercialization and Global Strategy - The conference will explore commercialization paths for surgical robots, comparing global market experiences and identifying real demands in different regions such as Europe, Southeast Asia, and the Middle East [8] - It will also address the financing challenges faced by surgical robotics and strategies for overcoming these hurdles [8] Group 5: Supply Chain and Ecosystem - The importance of building a complete medical robotics industry chain and the role of domestic core components will be discussed, highlighting opportunities and bottlenecks [13] - The conference will emphasize the need for standardized technology and collaborative mechanisms within the supply chain [13]

Core Viewpoint - The medical robotics industry is entering a complex phase by 2025, with evolving product forms, clearer clinical pathways, and a more rational capital environment, emphasizing the need for a comprehensive ecosystem [1] Group 1: Event Overview - The Third Global Surgical Robotics Conference will take place from September 3 to 5, 2025, in Beijing, focusing on the systematic upgrade of intelligent surgical systems and the construction of a full-chain ecosystem [1] - The conference will feature multiple government and industry leaders' speeches and the launch of the "Global Surgical Robotics Industry Report 2025" [2] Group 2: Technological Advancements - The next-generation surgical robots will focus on AI integration to enhance autonomy and system collaboration efficiency [7] - The evolution of surgical robots will involve mid-platform advancements in intraoperative navigation, imaging, and control [7] Group 3: Commercialization and Hospital Integration - The commercialization path for surgical robots will be analyzed through global market comparisons and experience extraction [7] - The decision-making process for hospital procurement will shift from evaluating "equipment" to assessing "systems" [7] Group 4: Global Strategies and Market Expansion - Different markets, including Europe, Southeast Asia, and the Middle East, have varying real demands for surgical robots [7] - Strategies for Chinese companies to achieve simultaneous certification from FDA, CE, and NMPA will be discussed [7] Group 5: Supply Chain and Ecosystem - The conference will address the challenges of integrating surgical robots with hospital systems and the need for a robust supply chain [8] - The importance of real-world data (RWD) in promoting registration and optimization of surgical robots will be highlighted [7]

Core Insights - Shenzhen Liuyedao Robot Co., Ltd. has completed a multi-million yuan A+ round of financing led by Yuehu Fund, aimed at enhancing its position in the domestic surgical robot market [1] - The company focuses on providing comprehensive AI surgical robot solutions for medical institutions, having developed a complete product and service system covering multiple key clinical areas [2] - Liuyedao Robot has achieved 100% localization of core components, significantly reducing production costs and promoting the widespread adoption of high-end surgical robots in various healthcare settings [3] Company Developments - The company has obtained multiple medical device registrations, including five Class III medical device certificates and one FDA 510(k) registration, showcasing its strong regulatory compliance [2] - Liuyedao Robot's products are currently in use in dozens of hospitals, facilitating the accessibility of robotic-assisted surgeries in grassroots medical institutions [3] - The chairman expressed gratitude for the support from Yuehu Fund and emphasized the company's commitment to accelerating the registration and market introduction of its surgical robots [5] Technological Advancements - The company has made significant breakthroughs in core technologies, achieving full domestic production of surgical robot components, which has disrupted the market previously dominated by imported products [5] - The RobPath-THA robot has achieved a 96.6% accuracy rate in acetabular installation, setting a new industry standard [6] - Liuyedao Robot's non-closed platform design and its integrated business model of "equipment + consumables + services" have created a new paradigm for medical technology development [6] Market Positioning - Established in 2018, Liuyedao Robot is positioned in four key surgical fields: spine/trauma, joint replacement, oral implantation, and vascular intervention [7] - The company collaborates with renowned medical institutions to create a robust research and innovation platform, enhancing its capabilities in medical engineering integration [7] - The financing will support the company's expansion into global markets and the development of new products, reinforcing its status as an industry benchmark [5]